Sandrock Alfred
SEC CIK 1577061 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | Pres, CEO, Dir | 472.5K | — | $620.4K | 15 | 2022-03-22 | 2026-04-02 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-03 17:55 | 2026-04-02 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.87 | -11.5K | 472.5K | -2% | -$44.5K |
| 2026-02-26 | 2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.79 | -14.2K | 484.1K | -3% | -$53.8K | |
| 2026-02-20 | 2026-02-18 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.41 | -11.7K | 498.3K | -2% | -$40.0K | |
| 2026-02-11 | 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.78 | -12.2K | 510.0K | -2% | -$46.1K | |
| D | 2026-02-10 | 2026-02-06 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +86.2K | 522.2K | +20% | $0 |
| 2025-04-04 | 2025-04-02 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $3.43 | -10.9K | 430.9K | -2% | -$37.3K | |
| D | 2025-02-24 | 2025-02-20 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $4.24 | -11.7K | 296.8K | -4% | -$49.6K |
| D | 2025-02-24 | 2025-02-21 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +145.0K | 441.8K | +49% | $0 |
| 2025-02-12 | 2025-02-11 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO | S - Sale | $4.45 | -16.6K | 308.5K | -5% | -$74.1K | |
| 2024-04-03 | 2024-04-02 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $9.86 | -12.1K | 322.8K | -4% | -$119.5K | |
| 2024-02-22 | 2024-02-21 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $7.46 | -13.0K | 335.0K | -4% | -$97.2K | |
| D | 2024-02-16 | 2024-02-09 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +130.0K | 348.0K | +60% | $0 |
| 2023-04-05 | 2023-04-03 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | S - Sale | $7.83 | -7,437 | 214.6K | -3% | -$58.2K | |
| D | 2023-02-22 | 2023-02-17 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +120.0K | 222.1K | +118% | $0 |
| D | 2022-03-23 | 2022-03-22 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Pres, CEO, Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations